LINCOLNSHIRE, Ill., July 23 /PRNewswire/ -- BioSante Pharmaceuticals, Inc.
(Amex: BPA) will present at the following forum:
What: BioSante Pharmaceuticals (Amex: BPA) will give a presentation at
Informed Investors Biotechnology /Healthcare Virtual Stocks Forum.
John McCamant, Editor, The Medical Technology Stock Letter, will deliver
the forum keynote address at 9 am.
When: July 27, 2004 @ 9:30 AM Eastern Time
How: Live over the Internet-Simply log on to the web at the address
Contact: Phillip Donenberg, Chief Financial Officer,
If you are unable to attend the live event, the forum will be available
via webcast at http://www.informedinvestors.com/IIF_Forum.asp?ForumID=85119.
BioSante is developing a pipeline of hormone therapy products to treat
both men and women. BioSante's hormone therapy products are gel formulations
for transdermal administration that deliver bioidentical estradiol and
testosterone. Symptoms treated with hormone therapy in men include impotence,
diminished sex drive, muscle weakness and osteoporosis. Symptoms in
menopausal women include hot flashes, vaginal atrophy, decreased libido and
osteoporosis. The estrogen and testosterone markets in the United States
alone account for over $2.5 billion in annual sales.
The company also is developing its calcium phosphate nanotechnology (CAP)
for novel vaccines, including biodefense vaccines for toxins such as anthrax
and ricin, and drug delivery systems. Additional information is available
online at http://www.biosantepharma.com.
FORUM CONTACT: Cary Loeser, Informed Investors, +1-804-327-3407,
Web site: http://www.informedinvestors.com
SOURCE Biosante Pharmaceuticals, Inc.